UK Parliamentary Committee Demands Termination of Palantir's $445M NHS Contract
Claire Weston
A UK parliamentary committee recommended triggering the break clause in the NHS's £330 million contract with Palantir, citing vendor lock-in risk — once deeply embedded, a single foreign supplier could hold public services hostage.
What is this contract?
The NHS Federated Data Platform contract was signed in 2023 for seven years, valued at £330 million (roughly $445 million). Its purpose: unify the NHS's scattered medical data onto one platform to support clinical decisions.
The contractor is U.S. data analytics firm Palantir (PLTR). This means → Britain's most critical public-health data infrastructure is being built and run by an American company.
The committee recommended the government activate the early termination clause by February next year and produce a plan to transition to UK-based suppliers by year-end.
What exactly is the committee worried about?
One phrase sits at the center: vendor lock-in. In plain terms = once the entire NHS data system runs on Palantir's platform, switching suppliers becomes near-impossible — the vendor can raise prices, cut quality, and you have no alternative.
Committee chair Chi Onwurah warned directly: once deeply embedded, a supplier could threaten to cut off service, which "could bring public services and the wider economy to a standstill."
The report also cited Palantir co-founder Peter Thiel's public remarks — he called the British public's attachment to the NHS "Stockholm syndrome" and said "the NHS makes people sick" — along with CEO Alex Karp's recent book and its 22-point manifesto asserting absolute loyalty to American interests. This reflects a concern that goes beyond commercial risk into questions of values and political allegiance.
How big is Palantir's UK footprint?
Since the UK government first used Palantir to track COVID-19 spread in 2020, Palantir and its partners have won contracts with the NHS, Ministry of Defence, and other agencies worth a combined ~$750 million.
Palantir's most recent quarterly UK revenue was $130 million, roughly 8% of total company revenue. This means → the UK is not a marginal market for Palantir — it is a material revenue stream.
Beyond the NHS deal, the committee demanded an explanation for why Palantir received a £240 million, three-year MoD data analytics contract without competitive tender.
What political groundwork has Palantir laid in Britain?
Prime Minister Keir Starmer visited Palantir's offices during a recent Washington trip. Palantir also hired a former aide to Nigel Farage, leader of Reform UK — the right-wing party currently leading national polls.
Palantir has pledged to invest £1.5 billion in the UK by 2030. Put simply = the company's UK strategy is "embed and build relationships" — capital commitments and political connections running in parallel.
Palantir's UK head Louis Mosley told the committee the company aims to "support democratically elected governments in delivering their mandate" and "does not hold political positions as a company."
What happens next?
The central government has two months to review the report and respond. But the committee report is advisory only — whether to act is entirely the government's call.
The committee stressed that its core concern is vendor lock-in risk, not a demand to "divest" from American tech companies, and is not ideologically motivated.
Foxglove advocacy director Donald Campbell put it bluntly: "Are you comfortable allowing a company that holds these kinds of publicly expressed views and ideology to play a central role in the British state — a role that may become increasingly difficult to reverse?"
Content is for reference only, not financial advice.